Sectra and Leica Biosystems first in the world to gain FDA clearance to utilize DICOM images for pathology diagnostics
This is the first time an FDA clearance within digital pathology allows the use of DICOM images for pathology diagnostics, which marks a significant step towards standardization in this field.
- This is the first time an FDA clearance within digital pathology allows the use of DICOM images for pathology diagnostics, which marks a significant step towards standardization in this field.
- Sectra received its first FDA clearance during the pandemic, in 2020.
- The pandemic made the need and value of remote work even in the field of pathology obvious and has helped boost the adoption of digital pathology in the US.
- The recent FDA clearance including the clearance to utilize DICOM images for pathology diagnostics therefore makes me very proud.